K. Augustin

发表

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.

R. Vij, J. Dipersio, S. Devine, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?

J. Dipersio, E. Dubberke, L. Mundy, 2006, Bone Marrow Transplantation.

Cladribine in the treatment of acute myeloid leukemia: a single-institution experience.

J. Welch, J. Dipersio, C. Abboud, 2009, Clinical lymphoma & myeloma.

Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem‐Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever

P. Westervelt, E. Dubberke, R. Reichley, 2009, Pharmacotherapy.

Granulocyte–colony‐stimulating factor–mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage

R. Vij, K. Trinkaus, J. Dipersio, 2006, Transfusion.

A phase II study of 5‐day intravenous azacitidine in patients with myelodysplastic syndromes

R. Vij, P. Westervelt, J. Dipersio, 2009, American journal of hematology.

Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG

R. Vij, P. Westervelt, J. Dipersio, 2009, Bone Marrow Transplantation.

Possible Liposomal Amphotericin B–Induced Nephrogenic Diabetes Insipidus

L. Weavind, T. Canada, K. Augustin, 2003, The Annals of pharmacotherapy.

Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

P. Westervelt, E. Dubberke, R. Reichley, 2010, Pharmacotherapy.

Comparative Evaluation of Single Fixed Dosing and Weight‐Based Dosing of Rasburicase for Tumor Lysis Syndrome

P. Westervelt, A. McBride, L. Boehmer, 2013, Pharmacotherapy.

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G‐CSF

J. Welch, R. Vij, P. Westervelt, 2009, American journal of hematology.

Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?

J. Dipersio, H. Khoury, K. Augustin, 2006, Bone Marrow Transplantation.

Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia

P. Westervelt, A. McBride, K. Augustin, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Implementing a Commercial Rule Base as a Medication Order Safety Net

Ervina Resetar, Joshua A. Doherty, Victoria J. Fraser, 2003, AMIA.